CAROLINE DAWSON: Open Payments
NPI 1578598322 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 24 payments from 11 companies in 2025. Trend: 2023 $136 · 2024 $269 · 2025 $769
Food & beverage: $769
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $387 |
| ABBVIE INC. | 3 | $70 |
| Novo Nordisk Inc | 4 | $65 |
| Sumitomo Pharma America, Inc. | 3 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $19 |
| Amgen Inc. | 1 | $18 |
Products named: AIRSUPRA, GEMTESA, ANDEXXA, Wegovy, UBRELVY, XIFAXAN, Kerendia, IMBRUVICA.
Industry payments across OH — which companies pay providers there.
